GlassScriptPhysician profile
Adrian J Goldszmidt
NPI 1962452185
$6,658.69
in general payments reported to CMS, 2019-2025
54 companies · $1,294 in 2025
The $1,294 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,362 · 2020: $663 · 2021: $829 · 2022: $911 · 2023: $695 · 2024: $905 · 2025: $1,294.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,894.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,893.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,840.17 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $905.99 | 2019-2025 | |
| Teva Pharmaceuticals USA, INC. | $322.82 | 2019-2025 | Ajovy, Austedo Xr, Austedo |
| Allergan, INC. | $314.51 | 2019-2022 | |
| Ucb, INC. | $309.38 | 2019-2024 | Briviact, Nayzilam, Rystiggo |
| Biogen, INC. | $278.65 | 2019-2025 | Tysabri, Vumerity, Plegridy |
| Genzyme Corporation | $192.71 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $172.52 | 2019-2021 | |
| Genentech USA, INC. | $151.46 | 2019-2025 | Ocrevus Zunovo |
| Lilly USA, LLC | $131.18 | 2019-2025 | Emgality |
| Neurelis, INC. | $113.50 | 2020-2025 | Valtoco |
| Emd Serono, INC. | $108.17 | 2019-2023 | Mavenclad |
| Amgen INC. | $107.26 | 2021-2025 | Uplizna |
| Penumbra, INC. | $107.18 | 2019 | |
| Janssen Scientific Affairs, LLC | $103.51 | 2024 | Xarelto |
Show all 53 companies
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adrian Goldszmidt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.